Search For "covid 19 patients"
Maharashtra government says COVID-19 recovery rate at 63 per cent
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 14 (ANI): The recovery rate of COVID-19 patients in Maharashtra currently stands at 63.02 per cent, Maharashtra government said on Tuesday.
Read More
Odisha's COVID-19 recovery rate at 64-65 pc: Chief Secy Asit Tripathy
Updated : 5 years, 8 months ago IST
Bhubaneswar (Odisha) [India], July 13 (ANI): The recovery rate of COVID-19 patients in Odisha is around 64-65 per cent while the fatality rate is at 0.48 per cent, which is among the lowest in the country, said state Chief Secretary Asit Tripathy on Monday.
Read More
Kejriwal to inaugurate Delhi's second plasma bank at LNJP Hospital tomorro
Updated : 5 years, 8 months ago IST
New Delhi [India], July 13 (ANI): As plasma therapy has proven to be instrumental in curing COVID-19 patients, the second plasma bank in the national capital will be started at the Lok Nayak Jai Prakash Narayan (LNJP) hospital which will be inaugurated by Chief Minister Arvind Kejriwal.
Read More
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
COVID-19: Hyderabad entrepreneur develops software to find hospitals with
Updated : 5 years, 8 months ago IST
Hyderabad (Telangana) [India], July 11 (ANI): An entrepreneur from Hyderabad has developed software for COVID-19 patients to find hospitals with bed availability.
Read More
'Contribution to nation': Actor-turned-nurse Shikha Malhotra counsels COVI
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 11 (ANI): Shikha Malhotra, actor and a degree holder in nursing, has been counselling COVID-19 patients at Mumbai's BMC Hospital for over past three months to help the nation in the fight against coronavirus.
Read More
India's tally of COVID-19 cured cases crosses 5 lakh, recovery rate 62.78
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): With 19,870 COVID-19 patients being cured and discharged in the last 24 hours, India's tally of cured and discharged cases crossed the 5 lakh mark on Saturday, taking the recovery rate to 62.78 per cent.
Read More
Railways to convert 503 coaches into isolation wards for Covid-19 patients
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): In a bid to provide additional healthcare facilities to Delhi-NCR residents to combat coronavirus, Northern Railways will provide 503 isolation coaches to be used as COVID-19 wards.
Read More
Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Read More
Bihar govt directs medical colleges to arrange 100 beds for COVID-19 patie
Updated : 5 years, 8 months ago IST
Patna (Bihar) [India], July 11 (ANI): Bihar Government has written to nine medical colleges across the state stating that considering the rise in the COVID-19 cases, it had directed to identify 50 per cent of the total beds available in the institutions as isolation wards, so all medical col
Read More
Study links abnormally high blood sugar to higher risk of death in COVID-1
Updated : 5 years, 8 months ago IST
Wuhan [China], July 11 (ANI): A new research from Wuhan, China shows that in COVID-19 patients, but without a previous diagnosis of diabetes, abnormally high blood sugar is associated with more than double the risk of death and also an increased risk of severe complications.
Read More
DCGI approves Itolizumab injection for restricted emergency use on COVID-1
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Read More